Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.

PubWeight™: 1.74‹?› | Rank: Top 3%

🔗 View Article (PMID 20884297)

Published in Lancet Infect Dis on September 29, 2010

Authors

Alessandro Remo Zanetti1, Luisa Romanò, Cristina Giambi, Anna Pavan, Vito Carnelli, Guglielmino Baitelli, Giancarlo Malchiodi, Edgardo Valerio, Antonella Barale, Maria Anna Marchisio, Domenico Montù, Alberto Eugenio Tozzi, Fortunato D'Ancona, study group

Author Affiliations

1: Department of Public Health-Microbiology-Virology, University of Milan, Milan, Italy. alessandro.zanetti@unimi.it

Articles citing this

The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy. BMC Infect Dis (2015) 0.87

Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix™ hexa: twelve years of experience in Italy. Hum Vaccin Immunother (2013) 0.85

Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccine. Hum Vaccin Immunother (2013) 0.85

Loss of antibodies, but not of protection. Lancet Infect Dis (2010) 0.82

Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination. Hum Vaccin Immunother (2013) 0.78

Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study. BMC Infect Dis (2010) 0.76

Lessons learnt over two decades of vaccination against hepatitis B in Italy. J Prev Med Hyg (2015) 0.75

Twenty years of universal vaccination against hepatitis B in Italy: achievements and challenges. J Public Health Res (2012) 0.75

Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: a cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy. Hum Vaccin Immunother (2016) 0.75

Persistence of immunity in healthy adults aged ≥ 50 years primed with a hepatitis B vaccine 3 years previously. Hum Vaccin Immunother (2015) 0.75

Presence of anti-HBs antibodies in blood donors 18-22 years after vaccination and implications for the selection of candidates for plasmapheresis for the production of hyperimmune plasma. Blood Transfus (2015) 0.75

Articles by these authors

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet (2005) 2.95

Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol (2004) 2.58

Resurgence of pertussis in Europe. Pediatr Infect Dis J (2005) 2.23

Close encounters in a pediatric ward: measuring face-to-face proximity and mixing patterns with wearable sensors. PLoS One (2011) 2.10

Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg Infect Dis (2002) 1.82

Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology (2004) 1.70

Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol (2012) 1.68

Waterborne outbreak of Norwalk-like virus gastroenteritis at a tourist resort, Italy. Emerg Infect Dis (2002) 1.65

Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine (2007) 1.53

Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy (2011) 1.34

Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy. Transfusion (2002) 1.32

Population dynamics among methicillin-resistant Staphylococcus aureus isolates in Germany during a 6-year period. J Clin Microbiol (2012) 1.24

Risk groups for hepatitis A virus infection. Vaccine (2003) 1.23

Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion (2008) 1.20

Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine (2007) 1.11

Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy. J Med Virol (2003) 1.09

Ten years of Hib vaccination in Italy: prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance. Vaccine (2011) 1.06

Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine (2005) 1.03

Chikungunya and dengue viruses in travelers. Emerg Infect Dis (2008) 1.00

Knowledge, attitude and practice in primary and secondary cervical cancer prevention among young adult Italian women. Vaccine (2012) 0.98

Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. Vaccine (2012) 0.98

Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level. Vaccine (2012) 0.95

Pediatric sentinel surveillance of vaccine-preventable diseases in Italy. Pediatr Infect Dis J (2002) 0.95

[Hospitalisation associated with Rotavirus gastroenteritis in Italy, 2001-2003, evaluated by means of ICD9-CM diagnostic codes]. Ig Sanita Pubbl (2007) 0.95

Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation. PLoS One (2013) 0.94

How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy. Vaccine (2005) 0.93

Incidence of malaria and risk factors in Italian travelers to malaria endemic countries. Travel Med Infect Dis (2010) 0.92

Hepatitis A, Italy. Emerg Infect Dis (2005) 0.92

Adult immunization policies in advanced economies: vaccination recommendations, financing, and vaccination coverage. Int J Public Health (2013) 0.89

Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply. J Clin Virol (2006) 0.88

A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines. BMC Infect Dis (2008) 0.86

Detection and quantitation of hepatitis E virus in human faeces by real-time quantitative PCR. J Virol Methods (2004) 0.86

An economic evaluation of varicella vaccination in Italian adolescents. Vaccine (2004) 0.85

Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy. Vaccine (2012) 0.85

Role of non-polio enterovirus infection in pediatric hemolytic uremic syndrome. Pediatr Nephrol (2002) 0.85

Botulism and preserved green olives. Emerg Infect Dis (2005) 0.85

Vaccines for women to prevent neonatal tetanus. Cochrane Database Syst Rev (2013) 0.84

Attitude of Italian physicians toward pertussis diagnosis. Hum Vaccin Immunother (2013) 0.84

Acute cerebellitis in varicella: a ten year case series and systematic review of the literature. Ital J Pediatr (2014) 0.84

Emerging and re-emerging viruses in the era of globalisation. Blood Transfus (2009) 0.83

Hepatitis E and lymphocytic leukemia in Man, Italy. Emerg Infect Dis (2013) 0.83

Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern Italy. BMC Infect Dis (2010) 0.83

Occult hepatitis B in blood donors: a description of two cases. Blood Transfus (2010) 0.83

Impact of health care providers' advice on vaccine refusal for children with an acute nervous system infection. Eur J Pediatr (2014) 0.83

The issue of mandatory vaccination for healthcare workers in Europe. Expert Rev Vaccines (2013) 0.83

Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment. J Med Virol (2006) 0.82

Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009? Vaccine (2010) 0.82

Pandemic influenza A/H1N1pdm in Italy: age, risk and population susceptibility. PLoS One (2013) 0.82

Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group. Blood Transfus (2011) 0.81

IGF-1 and growth response to adult height in a randomized GH treatment trial in short non-GH-deficient children. J Clin Endocrinol Metab (2014) 0.81

Growth failure in pediatric tubercular meningitis. Pediatr Infect Dis J (2014) 0.80

Interferon-gamma production by mononuclear cells in Bacille Calmette-Guérin-revaccinated healthy volunteers predicted long-term antimycobacterial responses in a randomized controlled trial. Vaccine (2013) 0.80

Reliable surveillance of tick-borne encephalitis in European countries is necessary to improve the quality of vaccine recommendations. Vaccine (2010) 0.79

Immunogenicity, reactogenicity and adherence to a combined hepatitis A and B vaccine in illicit drug users. Addiction (2004) 0.79

Immunogenicity, reactogenicity and adherence with hepatitis A vaccination among drug users. Drug Alcohol Depend (2004) 0.79

Clinical, epidemiological and virological features of acute hepatitis B in Italy. Infection (2015) 0.78

Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus. J Med Virol (2003) 0.78

On-demand hyoscine butylbromide for the treatment of self-reported functional cramping abdominal pain. Scand J Gastroenterol (2013) 0.78

Prevalence of psychiatric symptoms in children and adolescents one year after the 2009 L'Aquila earthquake. BMC Psychiatry (2014) 0.78

Transfusion of red blood cells from an HIV-RNA-positive/anti-HIV-negative donor without HIV infection in the recipient. Transfusion (2007) 0.78

Surveillance of hepatitis A virus in urban sewages and comparison with cases notified in the course of an outbreak, Italy 2013. BMC Infect Dis (2014) 0.77

[Smoking habits among 13-18 year old students in Lombardy]. Epidemiol Prev (2009) 0.77

Assessing vaccination coverage in the European Union: is it still a challenge? Expert Rev Vaccines (2011) 0.77

Exploring reasons for non-vaccination against human papillomavirus in Italy. BMC Infect Dis (2014) 0.77

Impact of a regional Hib vaccination programme in Italy. Vaccine (2002) 0.77

Does Breastfeeding Protect Young Infants from Pertussis? Case-Control Study and Immunologic Evaluation. Pediatr Infect Dis J (2016) 0.76

Prevention of hepatitis A by vaccination. Expert Opin Biol Ther (2003) 0.76

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain. BMC Endocr Disord (2015) 0.75

Authors' reply re: Transvaginal prolapse repair with or without the addition of a midurethral sling in women with genital prolapse and stress urinary incontinence: a randomised trial. BJOG (2015) 0.75

Does growth hormone treatment influence pubertal development in short children? Horm Res Paediatr (2011) 0.75

Risk factors for nosocomial bacteraemia in intensive care units vary depending on causative agents: results of a prospective surveillance study from 2003 to 2006. J Hosp Infect (2011) 0.75

Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy. Am J Epidemiol (2013) 0.75

Primary prevention of hepatitis C virus infection. Vaccine (2003) 0.75

Increasing incidence of Clostridium difficile ribotype 001 associated with severe course of the infection and previous fluoroquinolone use in the Czech Republic, 2015. Eur J Clin Microbiol Infect Dis (2017) 0.75

The acquired experience and the programs for the prevention of nosocomial infections in Lombardy. New Microbiol (2007) 0.75

Podcasts are yet to make an impact in paediatric journals. J Paediatr Child Health (2010) 0.75

[Public health consumption at the Varese health trust]. Ig Sanita Pubbl (2003) 0.75

CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles. Vaccine (2017) 0.75

Immune changes in animal breeders: a pilot study conducted in northern Italy. Ann Agric Environ Med (2012) 0.75

Predicting skin barrier dysfunction and atopic dermatitis in early infancy. J Allergy Clin Immunol Pract (2019) 0.75

[Assessment of a mass screening program for breast cancer in the Milan Health Unit 1 (ASL Provincia di Milano 1)]. Ig Sanita Pubbl (2003) 0.75

Pertussis vaccination for adolescents and adults. Expert Opin Biol Ther (2004) 0.75

[Human papillomavirus vaccine register]. Recenti Prog Med (2013) 0.75

Vaccines for women for preventing neonatal tetanus. Cochrane Database Syst Rev (2015) 0.75

Multicenter clinical study on the efficacy and safety of inhalable insulin aerosol in the treatment of type 2 diabetes. Chin Med J (Engl) (2008) 0.75

Liver injury during gastroenteritis in adults: a retrospective study in 727 cases. Am J Gastroenterol (2002) 0.75

Frequency of infectious diseases in immigrants in a Western European country: a population-based study. J Immigr Minor Health (2015) 0.75

Analysis of readability and quality of web pages addressing both common and uncommon topics in pediatric surgery. Eur J Pediatr Surg (2012) 0.75

Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study. Lancet Neurol (2020) 0.75

[Vaccines. Inequalities in vaccination offer in Italy: how to get over regional offer differences?]. Epidemiol Prev (2011) 0.75

[Obesity and cardiovascular risk in children]. Recenti Prog Med (2014) 0.75

[A new Emergency Department case management model for nonurgent patients]. Ig Sanita Pubbl (2012) 0.75

[Characterisation of an HBsAg mutant of hepatitis B virus (HBV) isolated from a dialysed patient involved in an occupational accident]. Med Lav (2005) 0.75